| Factor Information | |
|---|---|
| Data ID | 3780 |
| Factor | Bypass time (min) |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To identify risk factors for renal failure in patients with cyanotic CHD |
| p Value | 0.0005 |
| Conclusion | To lower the risk, cardiopulmonary bypass time should be kept as short as possible and adequate hydration should be maintained in combination with extended diuretic therapy. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 706 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/DORV, PS/TGA, ASD/VSD, PS, TAPVD/TGA, VSD/PAD, ES/PA, VSD/TA, restrictive VSD/other/ASD |
| Reference | |
|---|---|
| PMID | 10817857 |
| Year | 2000 |
| Title | Renal function after cardiopulmonary bypass surgery in cyanotic congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | ||
| Source | patients | |
| Region | Berlin, Germany | |
| Method | observaional study; Mann-Whitney U- test | |
| Race | European | |
| Disease History | N/A | |
| Treatment History | cardiac surgery | |
| Group | Cyanotic heart disease(Treatment) | ASD controls(Control) |
| Number | 22 | 6 |
| Age | 14 years (5–42 years) | 37 years (28–66 years) |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 140(78–284) min | 46(25–86) min |
